Table 1

Descriptive statistics for the mCPDAI on weeks 12 and 24

Treatment groupnBaseline mean (SD)Time-point mean (SD)Change* in mean (SD)Change* in p valueBetween-treatment p value†
Week 12
 ETN 50 mg twice weekly/50 mg once weekly3166.52 (2.21)3.26 (2.02)−3.26 (2.12)<0.00010.0492
 ETN 50 mg once weekly/50 mg once weekly3156.46 (2.16)3.55 (2.11)−2.92 (2.15)<0.0001
Week 24
 ETN 50 mg twice weekly/50 mg once weekly3276.59 (2.24)2.80 (2.16)−3.78 (2.34)<0.00010.6513
 ETN 50 mg once weekly/50 mg once weekly3236.42 (2.15)2.75 (2.04)−3.69 (2.33)<0.0001

  • ↵* Change from baseline.

  • ↵† Between-treatment analysis of covariance model for change in terms of baseline, site and treatment.

  • ETN, etanercept.